Evidence map›Paper›PMID 37505935›Full record

ArticleBrain pathology (Zurich, Switzerland)2023

Inorganic phosphate exporter heterozygosity in mice leads to brain vascular calcification, microangiopathy, and microgliosis.

Upasana Maheshwari, José M Mateos, Ulrike Weber-Stadlbauer, Ruiqing Ni, Virgil Tamatey, Sucheta Sridhar, Alejandro Restrepo, Pim A de Jong, Sheng-Fu Huang, Johanna Schaffenrath and 5 more

Open access · goldAbstract read
In one paragraph

Article in Brain pathology (Zurich, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 3 countries.

Upasana MaheshwariDepartment of Neurosurgery, Clinical Neuroscience Center, University Hospital Zurich, University of Zurich, Zurich, Switzerland.ORCID 0000-0001-7516-3099
José M MateosCenter for Microscopy and Image analysis, University of Zurich, Zurich, Switzerland.
Ulrike Weber-StadlbauerInstitute of Veterinary Pharmacology and Toxicology, University of Zurich-Vetsuisse, University of Zurich, Zurich, Switzerland.
Ruiqing NiNeuroscience Center Zurich, University of Zurich and ETH Zurich, Zurich, Switzerland.ORCID 0000-0002-0793-2113
Virgil TamateyResearch Centre for Natural Sciences, Institute of Enzymology, Budapest, Hungary.ORCID 0000-0002-0066-4945
Sucheta SridharDepartment of Neurosurgery, Clinical Neuroscience Center, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Alejandro RestrepoDepartment of Neurosurgery, Clinical Neuroscience Center, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Pim A de JongDepartment of Radiology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Sheng-Fu HuangDepartment of Neurosurgery, Clinical Neuroscience Center, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Johanna SchaffenrathDepartment of Neurosurgery, Clinical Neuroscience Center, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Sebastian A StifterInstitute of Experimental Immunology, University of Zurich, Zurich, Switzerland.
Flora SzeriResearch Centre for Natural Sciences, Institute of Enzymology, Budapest, Hungary.
Melanie GreterInstitute of Experimental Immunology, University of Zurich, Zurich, Switzerland.
Huiberdina L KoekDepartment of Geriatric Medicine, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands.
Annika KellerDepartment of Neurosurgery, Clinical Neuroscience Center, University Hospital Zurich, University of Zurich, Zurich, Switzerland.ORCID 0000-0003-1466-3633
University of Zurich · CHUtrecht University · NLEötvös Loránd University · HUInstitute of Molecular Life Sciences · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Calcification of the cerebral microvessels in the basal ganglia in the absence of systemic calcium and phosphate imbalance is a hallmark of primary familial brain calcification (PFBC), a rare neurodegenerative disorder. Mutation in genes encoding for sodium-dependent phosphate transporter 2 (SLC20A2), xenotropic and polytropic retrovirus receptor 1 (XPR1), platelet-derived growth factor B (PDGFB), platelet-derived growth factor receptor beta (PDGFRB), myogenesis regulating glycosidase (MYORG), and junctional adhesion molecule 2 (JAM2) are known to cause PFBC. Loss-of-function mutations in XPR1, the only known inorganic phosphate exporter in metazoans, causing dominantly inherited PFBC was first reported in 2015 but until now no studies in the brain have addressed whether loss of one functional allele leads to pathological alterations in mice, a commonly used organism to model human diseases. Here we show that mice heterozygous for Xpr1 (Xpr1

Indexed as

Brain DiseasesNeurodegenerative DiseasesVascular CalcificationAnimalsBrainHumansMiceMutationPhosphatesSodium-Phosphate Cotransporter Proteins, Type IIIXenotropic and Polytropic Retrovirus ReceptorPhosphatesSLC20A2 protein, humanSodium-Phosphate Cotransporter Proteins, Type IIIXenotropic and Polytropic Retrovirus Receptoracoustic startle responsedark microgliainflammationretinascanning electron microscopysexual dimorphism

Identifiers

PMID37505935
PMCPMC10580014
OpenAlexW4385350869

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.